Foment Bio

Foment Bio

Open  for investment

About this raise

Foment Bio, with a valuation of $17.5 million, is raising funds on StartEngine. It is a biopharmaceutical company developing a novel transient gene therapy platform to treat cardiometabolic dysfunction. Foment Bio’s transient gene therapy leads to regenerative exosome production inside the body and prevents cell death, reduces fibrosis, decreases inflammation, and restores microvasculature. The platform has high potential in human indications, but its development in the companion animal space offers a higher potential for near-term commercialization. Ben Chlebina and Marc Penn founded Foment Bio in February 2023. The current crowdfunding campaign has a minimum target of $124,000 and a maximum target of $1.24 million. The campaign proceeds will be used for legal and IP maintenance, research and development, manufacturing and inventory, and personnel expenses.

Expand

Investment Overview

Committed this round: $20,700

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
04/24/2025
Close Date
07/22/2025
Min. Goal
$124,000
Max Goal
$1,235,000
Min. Investment

$500

Security Type

SAFE

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$17,500,000

Discount

20%

Company & Team

Company

Year Founded
2023
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
High
Location
Montgomery, Texas
Business Type
Growth
Company Website
Visit Website

Team

Employees
3
Prior Founder Exits?
Yes
Founder Name
Ben Chlebina
Title
CEO
Founder Name
Marc Penn
Title
COO

Financials

 Revenue
$0
as of FY2024
 Monthly Burn
$35,000
as of Mar '25
 Runway
0.2 months
as of Mar '25

Summary Profit and Loss Statement

FY 2024 FY 2023

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-56,664

$0

Summary Balance Sheet

FY 2024 FY 2023

Cash

$7,538

$0

Accounts Receivable

$0

$0

Total Assets

$620,480

$0

Short-Term Debt

$134,594

$0

Long-Term Debt

$0

$0

Total Liabilities

$134,594

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$542,550
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
07/22/2025 StartEngine $17,500,000 $20,700 SAFE Active RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Foment Bio on StartEngine 2025
Platform: StartEngine
Security Type: SAFE
Valuation: $17,500,000

Follow company

Follow Foment Bio on StartEngine 2025

Buy Foment Bio's Deal Report

Foment Bio Deal Report

Get Kingscrowd's comprehensive report on Foment Bio including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Foment Bio is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Foment Bio deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge